Nanozyme-mediated redox and immune homeostasis in osteoarthritis and rheumatoid arthritis
Advanced Drug Delivery Reviews · 2026-12 · 239 · 115974
DOI: 10.1016/j.addr.2026.115974 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-12. Verfasst von Wali Muhammad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Advanced Organic Materials and Technologies, MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Interna…. Hauptthemen laut MEDLINE: Osteoarthritis, Arthritis, Rheumatoid. Die Arbeit nennt 251 Literaturangaben. Gefördert von: Higher Education Discipline Innovation Project, National Key Research and Development Program of China.
Abstract (Originalsprache)
Osteoarthritis (OA) and rheumatoid arthritis (RA) are inflammatory joint disorders that involve overlapping immune-cell populations with distinct etiologies. Key pathological features in the microenvironments of both OA and RA are redox imbalance, and dysregulated immune responses. From the perspective of the pathological microenvironment, a high level of reactive oxygen species (ROS) triggers inflammatory cascades, shifting macrophage polarization to an M1 (pro-inflammatory) phenotype, leading to cartilage erosion and tissue damage. Current therapeutics comprising anti-inflammatory drugs and antioxidant agents provide symptomatic relief, yet possess significant challenges, especially in addressing the interconnected axis (redox-immune axis). Nanozymes, catalytic nanomedicine with their enzyme-mimicking properties such as peroxidase (POD), superoxide dismutase (SOD), and catalase (CAT), alongside with high stability, adjustable catalytic activities and adaptability to specific microenvironment, have emerged as promising platform in arthritis treatment to restore redox homeostasis and immune responses. Moreover, microenvironment-adaptive and combinational nanozyme systems further advance targeted and multimodal therapeutic strategies in arthritis. This review highlights the pathological rationale for nanozymes in OA and RA, and explores nanozyme-immune crosstalk, focusing on redox homeostasis, immune regulation, and microenvironment-sensitive or combinational platforms. Furthermore, safety concerns regarding nanozyme treatment, and future avenues of research are drawn to advance nanozyme-based therapies for arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Advanced Organic Materials and Technologies, MOE Key Laboratory of Macromolecular Synthesis and Functionalization, International Research Center for X Polymers, Department of Polymer Science a…
Förderung
- Higher Education Discipline Innovation Project
- National Key Research and Development Program of China
Zitieren
APA
Muhammad, W., Kang, Y., Wang, X., Zheng, W., & Gao, C. (2026). Nanozyme-mediated redox and immune homeostasis in osteoarthritis and rheumatoid arthritis. Advanced Drug Delivery Reviews, 239, 115974. https://doi.org/10.1016/j.addr.2026.115974
Vancouver
Muhammad W, Kang Y, Wang X, Zheng W, Gao C. Nanozyme-mediated redox and immune homeostasis in osteoarthritis and rheumatoid arthritis. Advanced Drug Delivery Reviews. 2026;239:115974. doi:10.1016/j.addr.2026.115974
BibTeX
@article{Muhammad2026,
author = {Muhammad, Wali and Kang, Yongyuan and Wang, Xuelong and Zheng, Weiwei and Gao, Changyou},
title = {Nanozyme-mediated redox and immune homeostasis in osteoarthritis and rheumatoid arthritis},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {239},
pages = {115974},
doi = {10.1016/j.addr.2026.115974}
}
EUVIMED